Nordion Inc. (TSX: NDN; NYSE: NDZ), a leading provider of products and services to the global health science market, today announced that the Company will report its fourth quarter and fiscal 2012 financial results before markets open on January 28, 2013.
Fourth Quarter and Fiscal 2012 Conference Call
The Company will also host an analyst conference call with Steve West, Chief Executive Officer and Peter Dans, Chief Financial Officer, to discuss the results. The call will be webcast live on January 28, 2013 at 10:00 a.m. EST.
Interested parties may access the live webcast of the conference call from the Nordion website at
. To participate, please dial 1-866-223-7781 (toll-free North America) or 1-416-340-8018 (International). Following the call, an audio archive will be available on the website at
About Nordion Inc.
Nordion Inc. (TSX: NDN) (NYSE: NDZ) is a global health science company that provides market-leading products used for the prevention, diagnosis and treatment of disease. We are a leading provider of targeted therapies, sterilization technologies and medical isotopes that benefit the lives of millions of people in more than 60 countries around the world. Our products are used daily by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. Nordion has approximately 500 highly skilled employees worldwide. Find out more at
and follow us at